Wisconsin Clinical Trials

Recruiting studies in Wisconsin

• A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
  NCT05947851PHASE3Merck Sharp & Dohme LLCLeukemia, Lymphocytic, Chronic, B-CellMadison, WI
• Testing Short-Course Radiation Versus Standard-Course Radiation for Soft Tissue Sarcomas That Need Surgery and Radiation
  NCT07615049PHASE3SWOG Cancer Research NetworkRecurrent Soft Tissue Sarcoma of the Trunk and ExtremitiesMarshfield, WI
• Adding Pirtobrutinib to the Usual Treatment for People With Newly Diagnosed Richter Transformation, The PIRAMID Trial
  NCT07220187PHASE3SWOG Cancer Research NetworkRichter SyndromeMenomonee Falls, WI
• A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
  NCT07067463PHASE3Zenas BioPharma (USA), LLCMultiple Sclerosis (MS) Primary ProgressiveMilwaukee, WI
• Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
  NCT07697456PHASE2AbbVieCrohn's DiseaseMilwaukee, WI
• A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
  NCT05828069PHASE2National Cancer Institute (NCI)Recurrent Langerhans Cell HistiocytosisGreen Bay, WI
• Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).
  NCT06641414PHASE3Ascentage Pharma Group Inc.Higher-risk Myelodysplastic SyndromeMilwaukee, WI
• MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
  NCT05655312PHASE1, PHASE2Perspective TherapeuticsRecurrent Melanoma (Skin)Madison, WI
• Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System
  NCT07042295PHASE2National Cancer Institute (NCI)Locally Recurrent Skin Squamous Cell CarcinomaMenomonee Falls, WI
• A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
  NCT06312176PHASE3Merck Sharp & Dohme LLCBreast NeoplasmsMadison, WI
• A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
  NCT05920356PHASE3AmgenNon-Small Cell Lung Cancer (NSCLC)Janesville, WI
• Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
  NCT07195734PHASE2National Cancer Institute (NCI)Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Johnson Creek, WI

See all 1,116 recruiting trials →

Clinical trials by Wisconsin metro

• Milwaukee

Popular conditions in Wisconsin

• Breast Cancer
• Prostate Cancer
• Lung Cancer
• Colorectal Cancer
• Obesity
• Type 2 Diabetes
• Depression
• Alzheimer Disease
• Heart Failure
• Multiple Sclerosis
• Rheumatoid Arthritis
• Asthma
• Non-small Cell Lung Cancer
• Small Cell Lung Cancer
• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Frequently asked questions

How do I find clinical trials in Wisconsin?

Corterve aggregates actively recruiting clinical trials with sites in Wisconsin from the public ClinicalTrials.gov registry. Browse the studies on this page or take an assessment to find trials you may qualify for.

Are clinical trials in Wisconsin free to join?

Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.

What kinds of clinical trials are available in Wisconsin?

Wisconsin research sites run studies across many areas including oncology, neurology, cardiology, and metabolic health. This page is general information and not medical advice; confirm any specific trial with your healthcare provider.